Discover 700 paid clinical trials in Oklahoma. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Oklahoma offers many options for individuals interested in paid research studies as both healthy participants and those with specific health conditions. Leading research centers in Oklahoma City, Tulsa, and Norman are recruiting volunteers, giving access to the latest treatments and specialized care.
Filter
1
Filter results
Results: 700
Multidimensional Predictive Modeling to Understand Mechanisms of Exercise Response Heterogeneity in Older Adults (M3AX)
for
Aging, Aging Well
Location: Pensacola FL, Oklahoma City OK
Sponsor: Florida Institute for Human and Machine Cognition
Sex: All
Age: 60+
Code: NCT06507189
Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: St. John's, Bangor ME, Scarborough ME, Providence RI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase2, Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Spine Radiosurgery for Symptomatic Metastatic Neoplasms
for
Metastatic Neoplasm to the Spine, Metastatic Neoplasm
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 18+
Code: NCT05617716
Phase2, Recruiting
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
for
Chronic Spontaneous Urticaria (CSU)
Location: Boston MA, Farmington CT, The Bronx NY,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06868212
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Boston MA, Saint Johnsbury VT, Lebanon NH, The Bronx NY,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06532279
Phase2, Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Guilford CT, New Haven CT, Derby CT, Burlington VT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06649812
Phase2, Recruiting
Attitudes and Perceptions Attitudes and Smoking Perceptions in the Real Environment -II
for
Cigarillo Flavor
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 18 - 34
Code: NCT06668350
Recruiting
Nectero EAST System Clinical Study
for
Abdominal Aortic Aneurysm
Location: Boston MA, Worcester MA, Philadelphia PA, Bethlehem PA,
Sponsor: Nectero Medical, Inc.
Sex: All
Age: 21 - 70+
Code: NCT06001918
Phase2, Phase3, Recruiting
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
for
Lewy Body Dementia Psychosis
Location: Washington D.C. DC, Richmond VA, Boca Raton FL,
Sponsor: ACADIA Pharmaceuticals Inc.
Sex: All
Age: 55 - 70+
Code: NCT07029581
Phase2, Recruiting
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
for
Malignant Glioma
Location: Halifax, Bangor ME, Scarborough ME, Boston MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 21
Code: NCT05099003
Phase1, Phase2, Recruiting
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
for
Solid Cancer
Location: New Haven CT, Lake Success NY, New York NY, Teaneck NJ,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06161025
Phase2, Phase3, Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Scarborough ME, Boston MA, Providence RI, Worcester MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase2, Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Halifax, Hartford CT, New Haven CT, Quebec, Sherbrooke,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase2, Recruiting
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
for
Graves' Disease
Location: New Hyde Park NY, Long Island City NY, New York NY,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT07018323
Phase2, Recruiting
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
for
Chronic Rhinosinusitis Without Nasal Polyps
Location: Towson MD, Rochester NY, North Charleston SC,
Sponsor: Optinose US Inc.
Sex: All
Age: 12 - 17
Code: NCT06850805
Phase3, Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
for
Endometrial Cancer
Location: St. John's, Scarborough ME, Boston MA, Providence RI,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06952504
Phase3, Recruiting
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Location: The Bronx NY, New Brunswick NJ, Hershey PA,
Sponsor: UroGen Pharma Ltd.
Sex: All
Age: 18+
Code: NCT06774131
Phase3, Recruiting
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
for
Major Depressive Disorder
Location: Boston MA, Watertown MA, Methuen MA, Worcester MA,
Sponsor: Xenon Pharmaceuticals Inc.
Sex: All
Age: 18 - 70+
Code: NCT07076407
Phase3, Recruiting
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Damariscotta ME, Bath ME, Augusta ME, Brunswick ME,